The main limitation is the small sample size, which limits the ability to establish causation or generalize findings.
Journal of Clinical Medicine · 6 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The main limitation is the small sample size, which limits the ability to establish causation or generalize findings.
Long-gap esophageal atresia (LGEA) repair with the Foker process involves complex perioperative care, including repeated anesthesia and prolonged sedation, which may contribute to brain vulnerability. This study aimed to explore associations between easily quantifiable clinical measures and previously reported brain MRI findings in a pilot cohort of infants following LGEA repair. Clinical measures included disease severity scores (ASA, PRAm), anesthesia exposure (number of events, cumulative MAC hours), and durations of postoperative treatments (mechanical ventilation, muscle relaxation, antibiotics, steroids, TPN). Associations were tested using Spearman rho and multivariable linear regression. Key Results: Premature infants had higher ASA scores (IV in 69%). No significant associations were found between individual clinical measures and brain MRI findings, except for a positive association between antibiotic treatment length and number of cranial MRI findings in premature infants (r=0.718, p=0.009). However, the multivariable regression model showed that clinical measures together significantly predicted the number of cranial MRI findings (F(6,14)=3.12, p=0.037), but not brain or corpus callosum volumes. Limitations: The study is a small pilot (n=13/group) with potential bias from non-uniform MRI timing, underestimation of anesthesia exposure in transferred infants, and lack of pre-treatment MRI. Causation cannot be established, and prematurity is a confounder. Implications: The findings suggest that a combination of clinical measures may serve as indirect markers for brain abnormalities following LGEA repair, highlighting the need for larger studies and long-term neurodevelopmental follow-up.